Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile
Therapeutic Advances in Infectious Disease

@tainfdis

A SAGE Open Access journal | Publishing high-quality articles in infectious disease | Editor-in-Chief @andhen25 | IF 3.8

ID: 1227165552671690753

linkhttps://journals.sagepub.com/home/tai calendar_today11-02-2020 09:42:05

1,1K Tweet

991 Followers

1,1K Following

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

💉 In a small RCT of IL-7 for refractory MAC lung disease, IL-7 increased lymphocyte counts but failed to convert sputum cultures. Structural lung disease may trump immune dysfunction in driving outcomes. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

🚨 Submission Open! 🚨 🦠 Antimicrobial Resistance Mechanisms & Therapeutic Options for Difficult-to-treat Nosocomial Pathogens 🌍 📅 Deadline: Dec 31, 2025 📚 Submissions are now welcome! For full details, check out the link. journals.sagepub.com/topic/collecti…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

As SOT/HCT recipients and cellular therapy patients travel more, tailored pretravel evaluations are critical: risk stratification, vaccines, prophylaxis, and counseling. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

Whole Body FDG-PET/CT (WBP) in Endocarditis 📊 Management changed in 44.6% of cases—esp. in prosthetic/device-related IE 💊 Led to longer + suppressive abx ⚠️ No difference in mortality or LOS 👀 Highlights need for clearer guidance on WBP use in IE journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

High resistance to amoxicillin (>95%) in UTI pathogens in Nepal. E. coli & K. pneumoniae still largely susceptible to gentamicin; E. coli to nitrofurantoin too. Regional data critical for guiding empiric therapy. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

📍SFTS: Hemorrhagic fever by Bandavirus dabieense ✅ Favipiravir > Ribavirin ❌ Platelet transfusions don’t help ⚠️ IVIG, IFN, steroids may worsen outcomes 🧬 Tocilizumab, ruxolitinib, plasma exchange show promise 🚀 Future: FDA drug screens + multiomics journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

This vivid case of colonic hookworm bleeding in an HIV+ patient highlights the hidden toll of neglected tropical diseases—underdiagnosed, undertreated, yet responsible for enormous morbidity in low-resource settings. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

By 2050, antimicrobial resistance (AMR) may cause 10 million deaths annually. Not just superbugs—resistance is rising in fungi, viruses, and parasites. This review highlights the escalating threat of AMR journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

Is there a “weekend effect” in ICU care for infected patients? 🇯🇵 Analysis from Japanese ICUs (DIANA cohort) finds no significant difference in ICU discharge or mortality at 14/28 days between weekend vs weekday admissions. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

🚨 Rising drug-resistant #TB in Tanzania threatens SDG3 progress. Using Bayesian zero-inflated Poisson models, this study maps high-risk areas & identifies key drivers: sex, age, HIV status & prior TB treatment. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

🚨 Study from Malawi: Among people with HIV admitted to hospital, inability to walk unaided predicted in-hospital death as well as the full WHO or qSOFA scores (AUROC ~0.68–0.71). journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

Among adults with HIV in Zambia, kidney impairment (eGFR <60) affected 10.7%. Risk was significantly higher in older adults and those on DTG + TDF/3TC regimens. 🩺 Monitoring renal function in PLWH on ART is critical. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

🧫 In a microbiome sub-study of patients on antibiotics: 💊 Ampicillin, piperacillin-tazobactam,&meropenem → • ↑ Enterococcus faecium colonization • ↑ ARGs (blaTEM-1A, blaSHV-100, blaCMY-18) • ↓ beneficial anaerobes (Clostridium, Bifidobacterium) journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. Andrés Henao, MD, PhD journals.sagepub.com/topic/collecti…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

COVID-19 unmasked plastic bronchitis in a man with HIV & Kaposi sarcoma. Not all dyspnea in PWH is infection—think rare complications. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

TB care ≠ just antibiotics. In Ghana, many patients had persistently poor QOL after 6 months. Mental health, stigma, & social support must be addressed. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

🚨 Submission Open! 🚨 🦠 Antimicrobial Resistance Mechanisms & Therapeutic Options for Difficult-to-treat Nosocomial Pathogens 🌍 📅 Deadline: Dec 31, 2025 📚 Submissions are now welcome! For full details, check out the link. journals.sagepub.com/topic/collecti…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

From barrier to trigger: skin microbiota guard us but can also drive disease when balance falters. Latest review explores mechanisms and emerging microbiome therapies. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

📌 New study finds 33% of Hep B treatment-naïve patients already harbor primary antiviral resistance mutations—mostly rtV207M. ⚠️ No clear link to genotype or clinical factors 👉 Genotypic screening crucial to guide therapy and prevent treatment failure. journals.sagepub.com/doi/full/10.11…

Therapeutic Advances in Infectious Disease (@tainfdis) 's Twitter Profile Photo

Staph aureus bacteremia still deadly. β-lactam combos: faster clearance, variable survival benefit, AKI risk. journals.sagepub.com/doi/full/10.11…